Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,171,200 | 2,670,100 | 2,836,400 | 1,610,300 | 747,500 |
| Depreciation Amortization | 168,900 | 1,081,000 | 872,000 | 694,600 | 512,000 |
| Income taxes - deferred | 53,100 | 91,700 | -39,700 | -20,500 | 76,100 |
| Accounts receivable | -134,000 | -435,600 | -225,800 | -301,200 | -195,700 |
| Other Working Capital | -15,600 | 235,400 | -980,300 | -1,140,800 | -1,155,500 |
| Other Operating Activity | 213,500 | 908,400 | 570,100 | 562,000 | 250,800 |
| Operating Cash Flow | $1,457,100 | $4,551,000 | $3,032,700 | $1,404,400 | $235,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194,700 | -867,400 | -636,800 | -407,700 | -210,000 |
| Net Acquisitions | -600,000 | -1,200,000 | -900,000 | -600,000 | -300,000 |
| Purchase Of Investment | -1,919,200 | -5,355,200 | -4,093,900 | -2,536,000 | -1,256,700 |
| Sale Of Investment | 4,068,900 | 5,565,900 | 4,472,600 | 3,584,500 | 1,884,300 |
| Purchase Sale Intangibles | -10,000 | -1,095,400 | -1,030,400 | -980,300 | -855,200 |
| Other Investing Activity | -8,400 | -1,106,400 | -1,035,500 | -987,500 | -861,800 |
| Investing Cash Flow | $1,346,600 | $-2,963,100 | $-2,193,600 | $-946,700 | $-744,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -560,900 | -3,200 | N/A | N/A |
| Common Stock Issued | -21,200 | N/A | -10,700 | -17,800 | -25,500 |
| Common Stock Repurchased | -250,000 | -1,365,400 | -1,365,400 | -1,365,400 | -583,600 |
| Other Financing Activity | 2,600 | -453,700 | -292,600 | -269,200 | -292,300 |
| Financing Cash Flow | $-268,600 | $-2,380,000 | $-1,671,900 | $-1,652,400 | $-901,400 |
| Exchange Rate Effect | -900 | 39,400 | 54,400 | 37,800 | 7,900 |
| Beginning Cash Position | 1,573,800 | 2,326,500 | 2,326,500 | 2,326,500 | 2,326,500 |
| End Cash Position | 4,108,000 | 1,573,800 | 1,548,100 | 1,169,600 | 924,000 |
| Net Cash Flow | $2,534,200 | $-752,700 | $-778,400 | $-1,156,900 | $-1,402,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,457,100 | 4,551,000 | 3,032,700 | 1,404,400 | 235,200 |
| Capital Expenditure | -194,700 | -867,400 | -636,800 | -407,700 | -210,000 |
| Free Cash Flow | 1,262,400 | 3,683,600 | 2,395,900 | 996,700 | 25,200 |